Avidity Biosciences, Inc(NASDAQ:RNA) 
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment...
Website: http://www.aviditybiosciences.com
Founded: 2012
CEO: Sarah Boyce
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 26.93
H 27.82
L 26.23
C 26.57
V 1,841,168
10EMA 26.57
20EMA 26.57
60EMA 26.57
120EMA 26.57
250EMA 26.57